HOLLI NEWTON: Open Payments
NPI 1558432211 · LOGANVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 28 payments from 11 companies in 2025. Trend: 2023 $496 · 2024 $242 · 2025 $592
Food & beverage: $507Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $137 |
| Janssen Biotech, Inc. | 2 | $107 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $82 |
| Madrigal Pharmaceuticals | 4 | $68 |
| PFIZER INC. | 2 | $53 |
| Ardelyx, Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| GENZYME CORPORATION | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
Products named: TREMFYA, SKYRIZI, XIFAXAN, REZDIFFRA, XELJANZ, DUPIXENT, IBSRELA, MAVYRET.
Industry payments across GA — which companies pay providers there.
